| Previous close | 275.17 |
| Open | 275.17 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 630.00 |
| Expiry date | 2024-11-15 |
| Day's range | 275.17 - 275.17 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
Barrons.comThe Fed Needs to Cut Rates Eventually Amid This Economic Slowdown. Here’s Why, and 4 Other Things to Know Today.
Nvidia’s fight to remain the world’s most valuable company begins, disappointing retail sales raise hopes for a September rate cut, and more news to start your day.
ZacksCan Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?
On Jun 10, the FDA's Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted 11-0, unanimously recommending the approval of Eli Lilly's (LLY) Alzheimer's disease drug, donanemab.
Yahoo FinanceWhy the GLP-1 impact on other industries 'will take years'
Moody's released a new report Tuesday that reins in Wall Street expectations for the impact of GLP-1s on other industries.
© 2024 Yahoo. All rights reserved.